Medications

FDA OKs expanded use of prostate cancer drug

(HealthDay)—The approved use of the drug Zytiga has been expanded to include treatment of men with late-stage, hormone therapy-resistant prostate cancer before they undergo chemotherapy, the U.S. Food and Drug Administration ...

Oncology & Cancer

US approves radiation-based prostate cancer drug

(AP)—The U.S. Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones.

Medical research

A step toward treating chemotherapy-resistant prostate cancer

Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy medications—cisplatin. Now, researchers reporting in ACS Central Science have developed the first ...

Oncology & Cancer

Periodic bursts of genetic mutations drive prostate cancer

Cancer is typically thought to develop after genes gradually mutate over time, finally overwhelming the ability of a cell to control growth. But a new closer look at genomes in prostate cancer by an international team of ...

Oncology & Cancer

Study questions accepted treatment for prostate cancer

(Medical Xpress)—Contrary to the standard approach to treating metastatic prostate cancer, direct treatment of the primary tumor appears to prolong survival significantly, a new study by researchers at the University of ...

Oncology & Cancer

Video: Importance of exercise for men with prostate cancer

Prostate cancer is the second most common cancer in men worldwide. It's important that men are screened for the disease to catch it early, and a study in 2017 shows that exercise and physical activity as additional therapy ...

page 34 from 40